Release Date: July 11, 2025
Expiration Date: July 11, 2026
Activity Overview
This educational activity is an archive of the live presentation held on Saturday, May 31, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward hematologists/oncologists, medical oncologists, nurses, nurse practitioners, physician assistants, and other health care providers involved in the treatment and management of acute myeloid leukemia (AML).
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Incorporate individualized treatment plans for patients with AML based on guideline-directed molecular testing and risk stratification
- Assess emerging treatment strategies for AML across frontline and relapsed/refractory settings
- Apply findings from recent clinical trials to optimize AML treatment approaches
- Implement proactive strategies to monitor and manage treatment-related adverse events in patients with AML
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here